Yoshiyasu Shinohara

发表

Two-Colored Fluorescence Correlation Spectroscopy Screening for LC3-P62 Interaction Inhibitors

S. Yokoyama, F. Inagaki, N. Noda, 2013, Journal of biomolecular screening.

Long-term combination therapy of ezetimibe and acarbose for non-alcoholic fatty liver disease.

Hirokazu Takahashi, Y. Terauchi, H. Kirikoshi, 2009, Journal of hepatology.

Deficiency of eNOS exacerbates early-stage NAFLD pathogenesis by changing the fat distribution

Y. Terauchi, A. Nakajima, Y. Nagashima, 2015, BMC Gastroenterology.

Hyperresponsivity to low-dose endotoxin during progression to nonalcoholic steatohepatitis is regulated by leptin-mediated signaling.

H. Kirikoshi, A. Nakajima, K. Ikejima, 2012, Cell metabolism.

Semaphorin 4D, a lymphocyte semaphorin, enhances tumor cell motility through binding its receptor, plexinB1, in pancreatic cancer

I. Endo, Y. Goshima, T. Shimamura, 2011, Cancer science.

Oral choline tolerance test as a novel noninvasive method for predicting nonalcoholic steatohepatitis

H. Kirikoshi, A. Nakajima, M. Taguri, 2014, Journal of Gastroenterology.

Deficiency of iNOS-derived NO accelerates lipid accumulation-independent liver fibrosis in non-alcoholic steatohepatitis mouse model

Y. Terauchi, A. Nakajima, Y. Nagashima, 2015, BMC Gastroenterology.

Plasma free choline is a novel non‐invasive biomarker for early‐stage non‐alcoholic steatohepatitis: A multi‐center validation study

H. Kirikoshi, A. Nakajima, N. Matsuhashi, 2012, Hepatology research : the official journal of the Japan Society of Hepatology.

Unfolded protein response pathways regulate Hepatitis C virus replication via modulation of autophagy

N. Kato, M. Ikeda, H. Kirikoshi, 2013, Biochemical and Biophysical Research Communications.

Association between lipoprotein subfraction profile and the response to hepatitis C treatment in Japanese patients with genotype 1b

H. Kirikoshi, A. Nakajima, K. Kubota, 2010, Journal of viral hepatitis.

Hepatic triglyceride lipase plays an essential role in changing the lipid metabolism in genotype 1b hepatitis C virus replicon cells and hepatitis C patients

N. Kato, M. Ikeda, H. Kirikoshi, 2013, Hepatology research : the official journal of the Japan Society of Hepatology.

Association between phospholipids and free cholesterol in high‐density lipoprotein and the response to hepatitis C treatment in Japanese with genotype 1b

H. Kirikoshi, A. Nakajima, K. Kubota, 2010, Journal of viral hepatitis.

PPARs and Liver Disease

H. Kirikoshi, A. Nakajima, M. Yoneda, 2013 .

Soluble CD14 Levels Reflect Liver Inflammation in Patients with Nonalcoholic Steatohepatitis

H. Kirikoshi, A. Nakajima, K. Wada, 2013, PloS one.

Peroxisome Proliferator-Activated Receptor Gamma Exacerbates Concanavalin A-Induced Liver Injury via Suppressing the Translocation of NF-κB into the Nucleus

H. Kirikoshi, A. Nakajima, K. Wada, 2012, PPAR research.

Novel findings for the development of drug therapy for various liver diseases: Liver microsomal triglyceride transfer protein activator may be a possible therapeutic agent in non-alcoholic steatohepatitis.

Hirokazu Takahashi, T. Shimamura, H. Kirikoshi, 2011, Journal of pharmacological sciences.

Exposure to High Doses of Lipopolysaccharide during Ovalbumin Sensitization Prevents the Development of Allergic Th2 Responses to a Dietary Antigen

T. Tsujimura, S. Shimizu, A. Sato, 2014, Journal of toxicologic pathology.

Semaphorin 4D, a lymphocyte semaphorin, enhances tumor cell motility through binding its receptor, plexinB1, in pancreatic cancer

I. Endo, Y. Goshima, T. Shimamura, 2011, Cancer science.